Coulter:Partners
 Small-cap Placement News Bulletin – EU
 Q1 2019
 

Highlights

 
This quarter’s successful placements include:
  • President US Operations, regenerative medical technologies developer, UK
  • CEO, oncology, Belgium
  • CEO, cell therapy drug discovery, UK
  • Chief Operating Officer, infectious diseases, Netherlands
  • VP Clinical Operations & two Ambassador roles, medical devices, Belgium
  • Head of Manufacturing, drug delivery, Finland
  • VP Business Development, diagnostic technologies, Germany
  • Five senior managers (including 2 Country Managers), animal health, Sweden
  • Associate, Life Science venture capitalist, Switzerland
  • Board positions for four private equity and vc-backed European biotech companies; Chairman, Non Executive Director and Managing Director Operations
  • Other EU small-cap placement highlights include but are not limited to: VP Regulatory Affairs (rare diseases); Director Translational Medicine (Immuno-oncology); Research Director (gene therapy); SVP Preclinical Development x 3 (CNS, immuno-therapeutics)
Newly opened projects include:
  • Associate Investment Director, VC
  • Head of M&A, Healthcare Services
  • 2 Senior Associates, Life Science VC
  • Leadership assessment, CNS
  • CBO, immuno-oncology
  • CFO, 3D bioprinting technology
  • Head of Operations/ Head of QA, regenerative medicine

Themes

 
Areas of focus include but are not limited to:
  • Regenerative Medicine
  • CNS
  • Healthcare Services
  • Immuno-oncology
  • Genomics
  • Diagnostics
  • Gene Therapy
  • Medical Devices
  • Rare diseases

Coulter Partners

  • Global market leader and largest global executive search firm dedicated to the Life Sciences and committed to delivering outstanding leadership
  • 80+ sector experts from a diversity of backgrounds working across 12 global offices.
  • Unrivalled network with the Life Sciences community with 250+ assignments each year across all segments of the industry.
  • Deep understanding of talent needs, business models, sector trends, scientific evolution, innovation and competitive positioning
  • Large proportion of search work for VC, PE and angel-funded biotech, medtech, and digital health companies
  • Working with 50+ VC and PE funds across US, UK and EMEA
  • 400+ senior leadership assignments for investor portfolio companies

Contact Us


Bianca Coulter
London

b.coulter@
coulterpartners.com


Philipp Buis
Zurich

p.buis@
coulterpartners.com


Laura Esam
London

l.esam@
coulterpartners.com